Boston Scientific Corp (MIL:1BSX)
€ 85.5 0 (0%) Market Cap: 126.98 Bil Enterprise Value: 135.61 Bil PE Ratio: 74.26 PB Ratio: 6.39 GF Score: 56/100

Boston Scientific Corp at Piper Jaffray Healthcare Conference Transcript

Dec 05, 2019 / 04:00PM GMT
Matthew Oliver O;Brien
Piper Jaffray Companies, Research Division - MD and Senior Research Analyst

' -

All right. Good morning. Thanks so much for joining us. My name is Matt O'Brien. I cover devices here at Piper Jaffray. We've got Boston Scientific with us on stage here. Susie Lisa, who is the Head of HR -- or Head of HR -- Head of IR. So thanks for -- I don't think we have a joke for that. But thanks so much for joining us, and I know it's been a long day for you. So I do appreciate, again, you coming.

Susan Vissers Lisa
Boston Scientific Corporation - VP of IR

Thanks for having me. Battlefield promotion there maybe?

Questions & Answers

Matthew Oliver O;Brien
Piper Jaffray Companies, Research Division - MD and Senior Research Analyst

' -

Yes. Is that a promotion or a demotion? So let's talk about Q4 guide. You posted really strong Q3. Q4 you got a little bit easier comp, but 1 less selling day, you've guided to a little bit less than that. So are there some puts and takes in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot